Oral 1—Abstract Session 1: Molecular Biology and Chemotherapy
Oral 1.01. Phase II trial of amrubicin in patients with previously treated advanced thymic malignancies
Heather A. Wakelee, Sukhmani K. Padda, Matthew Burns, A. J. Spittler, Jonathan W. Riess, Melanie San Pedro-Salcedo, Kavitha J. Ramchandran, Matthew A. Gubens, Joel W. Neal, Patrick J. Loehrer Sr